Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

Study limitation reported by the research below: “The 'practice changing' impact flag reflects a strong phase 2b efficacy signal; duvakitug is not yet approved and phase 3 confirmation is needed before clinical adoption.”